Page last updated: 2024-11-10

5-methoxy-3-(di-n-propylamino)chroman

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-methoxy-3-(di-n-propylamino)chroman: labels central 5-HT receptor binding sites [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3082597
CHEMBL ID283606
SCHEMBL ID2217080
MeSH IDM0152925

Synonyms (17)

Synonym
5-methoxy-3-(dipropylamino)chroman
2h-1-benzopyran-3-amine, 3,4-dihydro-5-methoxy-n,n-dipropyl-
110927-00-9
5-methoxy-3-(di-n-propylamino)chroman
(5-methoxy-chroman-3-yl)-dipropyl-amine
bdbm50036862
5-meo-dpac
L023817
CHEMBL283606 ,
5-methoxy-n,n-dipropyl-3,4-dihydro-2h-chromen-3-amine
3-dipropylamino-5-methyloxychroman
3-(di-n-propylamino)-5-methoxychroman
GOWYIQOIWRLZLO-UHFFFAOYSA-N
5-methoxy-3,4-dihydro-n,n-dipropyl-2h-[1]-benzopyran-3-amine
SCHEMBL2217080
DTXSID90911898
5-methoxy-n,n-dipropyl-3,4-dihydro-2h-1-benzopyran-3-amine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)Ki0.01000.00010.739610.0000AID4411
D(2) dopamine receptorBos taurus (cattle)IC50 (µMol)0.10000.00100.79948.0000AID62167; AID62170
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)IC50 (µMol)20.00000.00051.48357.8000AID4671
DBos taurus (cattle)IC50 (µMol)100.00000.00100.47208.0000AID63046
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
synaptic transmission, dopaminergicD(2) dopamine receptorBos taurus (cattle)
negative regulation of prolactin secretionD(2) dopamine receptorBos taurus (cattle)
negative regulation of lactationD(2) dopamine receptorBos taurus (cattle)
positive regulation of mammary gland involutionD(2) dopamine receptorBos taurus (cattle)
hyaloid vascular plexus regressionD(2) dopamine receptorBos taurus (cattle)
synaptic transmission, dopaminergicDBos taurus (cattle)
vasodilationDBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
Golgi membraneD(2) dopamine receptorBos taurus (cattle)
endoplasmic reticulum membraneDBos taurus (cattle)
dendritic spineDBos taurus (cattle)
ciliary membraneDBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID35897Binding affinity against alpha-2 adrenergic receptor in calf frontal cortex1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.
AID4668Binding affinity for 5-hydroxytryptamine 1B receptor in rat cortex, striatum and globus pallidus1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.
AID4411Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement1996Journal of medicinal chemistry, Jan-05, Volume: 39, Issue:1
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
AID62167Binding affinity against D2 receptor in calf caudate nucleus1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.
AID63044Binding affinity towards dopamine receptor D1 in calf striatum1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.
AID35845Binding affinity against alpha-1 adrenergic receptor in calf frontal cortex1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.
AID5006Binding affinity towards 5-hydroxytryptamine 2 receptor in calf frontal cortex1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.
AID63046Displacement of [3H]raclopride from Dopamine receptor D1 of calf striatum1996Journal of medicinal chemistry, Oct-11, Volume: 39, Issue:21
3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].
AID3738Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding (NSB)1996Journal of medicinal chemistry, Oct-11, Volume: 39, Issue:21
3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].
AID5007Binding affinity to 5-hydroxytryptamine 2 receptor using calf frontal cortex, [3H]- ketanserin, and spiperone for NSB1996Journal of medicinal chemistry, Oct-11, Volume: 39, Issue:21
3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].
AID3734Binding affinity against 5-hydroxytryptamine 1A (5-HT1A) receptor in rat hippocampus membranes1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.
AID62170Displacement of [3H]SDZ-205-501 from Dopamine receptor D2 in calf caudate nucleus.1996Journal of medicinal chemistry, Oct-11, Volume: 39, Issue:21
3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].
AID4671Binding affinity to 5-HT1B receptors using rat cortex+striatum + globus pallidus,[3H]-5-OH-tryptamine, and serotonin for NSB1996Journal of medicinal chemistry, Oct-11, Volume: 39, Issue:21
3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's4 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.67 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]